Technical Analysis for PETX - Aratana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.67 -4.18% -0.16
PETX closed down 4.18 percent on Friday, March 22, 2019, on 37 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical PETX trend table...

Date Alert Name Type % Chg
Mar 22 20 DMA Resistance Bearish 0.00%
Mar 21 Fell Below 20 DMA Bearish -4.18%
Mar 20 1,2,3 Retracement Bearish Bearish Swing Setup -8.93%
Mar 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -8.93%
Mar 20 Crossed Above 20 DMA Bullish -8.93%
Mar 20 Up 3 Days in a Row Strength -8.93%
Mar 18 MACD Bullish Signal Line Cross Bullish -3.67%
Mar 18 Outside Day Range Expansion -3.67%
Mar 15 Bearish Engulfing Bearish 0.27%
Mar 15 MACD Bearish Signal Line Cross Bearish 0.27%

Older signals for PETX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Medicine Health Biopharmaceutical Pain Surgery Medication Inflammation Osteoarthritis Arthritis Aging Associated Diseases Rheumatology Skeletal Disorders
Is PETX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.16
52 Week Low 3.3
Average Volume 673,331
200-Day Moving Average 5.1531
50-Day Moving Average 4.162
20-Day Moving Average 3.889
10-Day Moving Average 3.79
Average True Range 0.2151
ADX 41.5
+DI 13.7125
-DI 31.3012
Chandelier Exit (Long, 3 ATRs ) 3.7647
Chandelier Exit (Short, 3 ATRs ) 3.9453
Upper Bollinger Band 4.2022
Lower Bollinger Band 3.5758
Percent B (%b) 0.15
BandWidth 16.106968
MACD Line -0.1486
MACD Signal Line -0.1736
MACD Histogram 0.0249
Fundamentals Value
Market Cap 157.82 Million
Num Shares 43 Million
EPS -1.61
Price-to-Earnings (P/E) Ratio -2.28
Price-to-Sales 26.68
Price-to-Book 2.44
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.02
Resistance 3 (R3) 4.05 3.97 3.96
Resistance 2 (R2) 3.97 3.88 3.95 3.94
Resistance 1 (R1) 3.82 3.83 3.78 3.79 3.92
Pivot Point 3.74 3.74 3.72 3.72 3.74
Support 1 (S1) 3.59 3.65 3.55 3.56 3.42
Support 2 (S2) 3.51 3.60 3.49 3.40
Support 3 (S3) 3.36 3.51 3.38
Support 4 (S4) 3.33